You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hereditary epidermolysis bullosa

Showing 1 - 25 of 881
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Epidermolysis Bullosa Trial in Paris (Cannabidiol)

Not yet recruiting
  • Hereditary Epidermolysis Bullosa
  • Paris, France
    Hôpital Necker Enfants Malades
Dec 7, 2022

Complex Care Training of Hereditary Epidermolysis Bullosa on

Not yet recruiting
  • Hereditary Epidermolysis Bullosa
  • Complex Care Training of Hereditary Epidermolysis Bullosa
  • Paris, France
    Assistance Publique - Hôpitaux de Paris
Feb 9, 2022

Weak or Strong Opioid Analgesics at Time of Care in Hereditary

Completed
  • Epidermolysis Bullosa
  • Interview
  • Paris, France
    Hôpital Necker-Enfants Malades
Sep 22, 2021

Epidermolysis Bullosa Trial in Paris (Ropivacaine, Blood test)

Completed
  • Epidermolysis Bullosa
  • Paris, France
    Hôpital Necker Enfants Malades
Apr 2, 2021

Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional Trial in Paris (CACIPLIQ20, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa Dystrophica
  • Epidermolysis Bullosa, Junctional
  • CACIPLIQ20
  • Placebo
  • Paris, France
    Hopital Necker - enfants malades
Aug 17, 2023

Recessive Dystrophic Epidermolysis Bullosa Trial (Spincare matrix)

Not yet recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • Spincare matrix
  • (no location specified)
Jul 12, 2023

Epidermolysis Bullosa, Oral Ulcer Trial in Santiago (Dentoxol mouthrinse dosages)

Enrolling by invitation
  • Epidermolysis Bullosa
  • Oral Ulcer
  • Dentoxol mouthrinse dosages
  • Santiago, Región Metropolitana, Chile
    Facultad de Odontología, Universidad de Chile
Apr 6, 2022

Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    Masonic Cancer Center and Medical Center Minneapolis
Apr 20, 2023

The State of Sexual Development in Inherited Epidermolysis

Active, not recruiting
  • Dermatologic Disease
  • +7 more
  • Biochemical study of hormone levels
  • +3 more
  • Moscow, Russian Federation
    National Medical Research Center for Children's Health
Aug 26, 2021

Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa Trial in United States (RGN-137, Placebo)

Terminated
  • Junctional Epidermolysis Bullosa
  • Dystrophic Epidermolysis Bullosa
  • Evanston, Illinois
  • +4 more
Aug 18, 2022

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Generalized Epidermolysis Bullosa Simplex Trial (AC-203, Vehicle)

Not yet recruiting
  • Generalized Epidermolysis Bullosa Simplex
  • (no location specified)
Oct 3, 2023

Growth Hormone in EB

Not yet recruiting
  • Epidermolysis Bullosa Dystrophica
  • growth hormone level and insulin like growth factor 1
  • (no location specified)
May 24, 2022

Artificial Intelligence Patient App for RDEB SCCs

Recruiting
  • Epidermolysis Bullosa Dystrophica
  • online survey
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
May 3, 2023

Recessive Dystrophic Epidermolysis Bullosa Trial in United States (FCX-007 (dabocemagene autoficel; see below for FCX-007

Active, not recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • FCX-007 (dabocemagene autoficel; see below for FCX-007 description)
  • Stanford, California
  • +4 more
Aug 10, 2022

Epidermolysis Bullosa Trial in Chicago (APR-TD011)

Not yet recruiting
  • Epidermolysis Bullosa
  • APR-TD011
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Sep 6, 2022

Recessive Dystrophic Epidermolysis Bullosa Trial in Worldwide (allo-APZ2-EB)

Completed
  • Recessive Dystrophic Epidermolysis Bullosa
  • allo-APZ2-EB
  • Minneapolis, Minnesota
  • +5 more
Oct 6, 2022

Epidermolysis Bullosa Trial (allo-APZ2-OTS, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa
  • (no location specified)
Jul 18, 2022

Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, New York (PTR-01)

Completed
  • Recessive Dystrophic Epidermolysis Bullosa
  • Redwood City, California
  • +1 more
Nov 17, 2022

Dystrophic Epidermolysis Bullosa Trial (AGLE 102)

Not yet recruiting
  • Dystrophic Epidermolysis Bullosa
  • AGLE 102
  • (no location specified)
Apr 7, 2022

Epidermolysis Bullosa Simplex Trial in Redwood City (TolaSure Topical Gel, Vehicle Topical Gel)

Recruiting
  • Epidermolysis Bullosa Simplex
  • TolaSure Topical Gel
  • Vehicle Topical Gel
  • Redwood City, California
    Stanford University School of Medicine, Dermatology Department
Jul 18, 2022

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica Trial in Worldwide (INM-755

Recruiting
  • Epidermolysis Bullosa Simplex
  • +3 more
  • INM-755 (cannabinol) cream
  • Vehicle Cream
  • Salzburg, Austria
  • +6 more
Mar 30, 2022

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, Worcester (EB-101)

Active, not recruiting
  • Epidermolysis Bullosa
  • Recessive Dystrophic Epidermolysis Bullosa
  • EB-101
  • Redwood City, California
  • +1 more
Apr 5, 2022

Patients With Hereditary Epidermolysis Bullosa

Completed
  • Epidermolysis Bullosa
  • clinical exam
  • Nice, France
  • +1 more
Jan 2, 2020